Lu, Hsiao YunHsiao YunLuYI-JOU TAIYU-LI CHENYING-CHENG CHIANGHsu, Heng ChengHeng ChengHsuWEN-FANG CHENG2021-08-272021-08-27202120050380https://scholars.lib.ntu.edu.tw/handle/123456789/579754Cytoreductive surgery followed by adjuvant chemotherapy is a standard frontline treatment for epithelial ovarian cancer (EOC). We aimed to develop an ovarian cancer risk score (OVRS) based on the expression of 10 ovarian-cancer-related genes to predict the chemoresistance, and outcomes of EOC patients.enDrug Resistance; Gene Analysis; Ovarian Cancer; Prognostic Factor; Risk Score[SDGs]SDG3[SDGs]SDG5CA 125 antigen; CA 19-9 antigen; carcinoembryonic antigen; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor; platinum complex; adult; Article; cancer prognosis; cancer staging; cancer survival; case control study; clinical decision making; clinical protocol; controlled study; cytoreductive surgery; data base; disease course; disease free survival; drug resistance; female; human; human tissue; major clinical study; middle aged; nuclear magnetic resonance imaging; outcome assessment; ovarian cancer risk score; ovary carcinoma; overall survival; quantitative analysis; real time polymerase chain reaction; receiver operating characteristic; risk assessment; scoring system; survival rate; drug resistance; genetics; ovary tumor; risk factor; Carcinoma, Ovarian Epithelial; Case-Control Studies; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Risk Factorsjournal article10.3802/jgo.2021.32.e18333270482-s2.0-85102357399https://scholars.lib.ntu.edu.tw/handle/123456789/554301